What does FARMALIA do?

FARMALIA is a pharmacy in Etterbeek. Private Limited, started on 29 May 2015, 1 establishment.

What is the address of FARMALIA?

The registered office of FARMALIA is located at Tervatestraat 59, 1040 Etterbeek.

Is FARMALIA still active?

Yes. According to the CBE (1 October 2026) FARMALIA is active, legal situation “Normale toestand”, started on 29 May 2015.

Is FARMALIA registered on Peppol?

Yes, FARMALIA is registered on the Peppol network with ID 0208:0630931055.

What is the enterprise number of FARMALIA?

The enterprise number of FARMALIA is BE0630931055.

When was FARMALIA founded?

FARMALIA was founded on 29 May 2015.

Who are the directors of FARMALIA?

According to the 2025 annual accounts, the directors of FARMALIA are: GRACE KARIM.

Is FARMALIA a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 29 May 2015; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did FARMALIA make in 2025?

FARMALIA posted a profit after taxes of € 8,777 in financial year 2025.

What is the revenue of FARMALIA?

As a small company, FARMALIA is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 43,692.

Does FARMALIA have a website?

Yes, FARMALIA has a website at etterbeek.city.

FARMALIA (Private Limited) - Etterbeek - BE0630931055

Dossier FARMALIA, printed on 1 October 2026 from databakkes.be/en/0630931055/farmalia. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Negative equity NBB

More debt than assets in 4 of the last 4 fiscal years.
Tight liquidity NBB

Cash and receivables cover 54 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

FARMALIA from Etterbeek, company number BE0630931055, closed financial year 2025 with a result of € 8,777 after tax. For that financial year FARMALIA recorded a gross margin of € 43,692 and equity of € -15,097. Compared with financial year 2024, the result moved from € 4,124 to € 8,777. Profitable, and profit is growing. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 15, 2026.

What it is worth Caution

€ -15,097

▲ € 8,777 vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 8,777

▲ 113% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 17,805

▼ 10% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € -33,697.

Debts at end 2025

Bank debt ≈ 10 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 326,342

▼ 9% vs 2024

€ 30,723 is repaid this year. At this pace the long-term loan is gone in ≈ 10 years.

Owed to suppliers

€ 86,530

▲ 3% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 21,364 Gross margin 2022: € 21,364 First fiscal year in the series	€ 43,205 Gross margin 2023: € 43,205 ▲ 102% vs 2022 (€ 21,364) Favourable step	€ 55,836 Gross margin 2024: € 55,836 ▲ 29% vs 2023 (€ 43,205) Favourable step	€ 43,692 Gross margin 2025: € 43,692 ▼ 22% vs 2024 (€ 55,836) Unfavourable step	▼ 22%
Profit after taxes	€ -50,070 Profit after taxes 2022: € -50,070 First fiscal year in the series	€ -11,146 Profit after taxes 2023: € -11,146 ▲ € 38,925 vs 2022 (€ -50,070) Favourable step	€ 4,124 Profit after taxes 2024: € 4,124 ▲ € 15,270 vs 2023 (€ -11,146) Favourable step	€ 8,777 Profit after taxes 2025: € 8,777 ▲ 113% vs 2024 (€ 4,124) Favourable step	▲ 113%
Equity	€ -16,852 Equity 2022: € -16,852 First fiscal year in the series	€ -27,998 Equity 2023: € -27,998 ▼ € 11,146 vs 2022 (€ -16,852) Unfavourable step	€ -23,874 Equity 2024: € -23,874 ▲ € 4,124 vs 2023 (€ -27,998) Favourable step	€ -15,097 Equity 2025: € -15,097 ▲ € 8,777 vs 2024 (€ -23,874) Favourable step	▲ € 8,777
Total debts	€ 550,983 Total debts 2022: € 550,983 First fiscal year in the series	€ 494,942 Total debts 2023: € 494,942 ▼ 10% vs 2022 (€ 550,983) Favourable step	€ 445,648 Total debts 2024: € 445,648 ▼ 10% vs 2023 (€ 494,942) Favourable step	€ 412,872 Total debts 2025: € 412,872 ▼ 7% vs 2024 (€ 445,648) Favourable step	▼ 7%
Cash	€ 53,332 Cash 2022: € 53,332 First fiscal year in the series	€ 27,472 Cash 2023: € 27,472 ▼ 48% vs 2022 (€ 53,332) Unfavourable step	€ 19,754 Cash 2024: € 19,754 ▼ 28% vs 2023 (€ 27,472) Unfavourable step	€ 17,805 Cash 2025: € 17,805 ▼ 10% vs 2024 (€ 19,754) Unfavourable step	▼ 10%
Land & buildings	€ 279,431 Land & buildings 2022: € 279,431 First fiscal year in the series	€ 270,110 Land & buildings 2023: € 270,110 ▼ 3% vs 2022 (€ 279,431) Unchanged	€ 260,789 Land & buildings 2024: € 260,789 ▼ 3% vs 2023 (€ 270,110) Unchanged	€ 251,468 Land & buildings 2025: € 251,468 ▼ 4% vs 2024 (€ 260,789) Unchanged	▼ 4%
Retained profit	€ -35,452 Retained profit 2022: € -35,452 First fiscal year in the series	€ -46,598 Retained profit 2023: € -46,598 ▼ € 11,146 vs 2022 (€ -35,452) Unfavourable step	€ -42,474 Retained profit 2024: € -42,474 ▲ € 4,124 vs 2023 (€ -46,598) Favourable step	€ -33,697 Retained profit 2025: € -33,697 ▲ € 8,777 vs 2024 (€ -42,474) Favourable step	▲ € 8,777
Bank debt	€ 478,373 Bank debt 2022: € 478,373 First fiscal year in the series	€ 422,248 Bank debt 2023: € 422,248 ▼ 12% vs 2022 (€ 478,373) Favourable step	€ 360,077 Bank debt 2024: € 360,077 ▼ 15% vs 2023 (€ 422,248) Favourable step	€ 326,342 Bank debt 2025: € 326,342 ▼ 9% vs 2024 (€ 360,077) Favourable step	▼ 9%
Balance sheet total	€ 534,131 Balance sheet total 2022: € 534,131 First fiscal year in the series	€ 466,944 Balance sheet total 2023: € 466,944 ▼ 13% vs 2022 (€ 534,131) Unchanged	€ 421,773 Balance sheet total 2024: € 421,773 ▼ 10% vs 2023 (€ 466,944) Unchanged	€ 397,775 Balance sheet total 2025: € 397,775 ▼ 6% vs 2024 (€ 421,773) Unchanged	▼ 6%

Key figures of FARMALIA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to FARMALIA?

What happened at FARMALIA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 15, 2026 New annual accounts for financial year 2025: profit of € 8,777 (▲ 113% vs 2024). Source: NBB ↗
Jul 1, 2015 New establishment in Etterbeek. KBO
May 29, 2015 Start of the company according to the CBE. KBO

In short

From € 50,070 loss in 2022 to € 8,777 profit in 2025.

Paid € 515 in corporate taxes since 2022.

Best year ever: 2025, with € 8,777 profit.

Original PDFs at the National Bank ↗

A new publication or filing at FARMALIA? We notify you, reason included.

Follow FARMALIA

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

GRACE KARIM

FARMALIA

Behind FARMALIA is GRACE KARIM.

See the full network in the app

Directors

According to the 2025 annual accounts

GRACE KARIM

Administrator-manager

Establishments

Establishment units

Physical locations of this company

Registered office

Tervatestraat 59

1040 Etterbeek

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTPS etterbeek.city

Technologies

ApacheBootstrapFont AwesomeLightboxMatomoPHPSwiperjQueryjQuery UIreCAPTCHA

Hosting & Email

Email provider

Self-hosted

Hosting

OVH, FR

Website info

HTTPS Ja

Languages FR

Features

Contact page

Security

✓ HTTPS

✓ SPF

✓ DMARC

Details

Company number: 0630.931.055
VAT number: BE 0630.931.055
Registered office: Tervatestraat 59, 1040 Etterbeek
Names & denominations: FARMALIA
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 29 May 2015
Peppol: Active · Active since 25 Apr 2024
Contact: etterbeek.city
Activities · NACE: Detailhandel in farmaceutische producten

View on CBE Public ↗ Annual accounts (NBB) ↗